Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Gabapentinoide

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. 

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. 

Cardoner N, Gutiérrez-Rojas L, Saiz P, Lahera G, Álvarez-Mon MÁ, Alonso Ortega P, Pérez-Páramo M.

Front Pharmacol. 2025 Feb 7;16:1483770. doi: 10.3389/fphar.2025.1483770. PMID: 39989902; PMCID: PMC11842937.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11842937/